ReviewFrontiers in immunology2023
The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.
Lincoln N Strickland et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it